1. Home
  2. DNUT vs RCKT Comparison

DNUT vs RCKT Comparison

Compare DNUT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$2.87

Market Cap

524.0M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$2.20

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
RCKT
Founded
1937
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
524.0M
239.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
DNUT
RCKT
Price
$2.87
$2.20
Analyst Decision
Hold
Buy
Analyst Count
7
14
Target Price
$4.08
★ $8.58
AVG Volume (30 Days)
1.8M
★ 2.2M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.37
EPS
N/A
★ 0.66
Revenue
★ $1,522,616,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.20
$915.60
P/E Ratio
★ N/A
$3.52
Revenue Growth
N/A
★ N/A
52 Week Low
$2.83
$2.17
52 Week High
$4.75
$5.45

Technical Indicators

Market Signals
Indicator
DNUT
RCKT
Relative Strength Index (RSI) 38.89 33.80
Support Level $2.86 N/A
Resistance Level $3.72 $3.70
Average True Range (ATR) 0.11 0.17
MACD 0.01 0.00
Stochastic Oscillator 11.43 6.50

Price Performance

Historical Comparison
DNUT
RCKT

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: